Larvol Delta - SOLSTICE-week-48-subgroup-analysis-Impact-of-BMI-on-ALT-normalization-after-successful-viral-control-in-participants-with-chronic-hepatitis-delta-virus-infection-treated-with-tobevibart-plus-elebsiran

tobevibart (VIR-3434) - Vir Biotech

elebsiran (VIR-2218) - Alnylam, Vir Biotech

https://pag.virtual-meeting.org/easl/easl2026/en-GB/pag/presentation/611608

Alina Jucov

May 27, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next